Young MRL/MPJ-Ipr (1pr) mice 8-12 wk old challenged with alloantigen had significantly lower specific cytolytic T lymphocyte (CTL) responses than control MRL/MPJ +/+ mice. Serum from lpr mice compared with serum from + + or normal C3H mice powerfully suppressed CTL responses in mixed lymphocyte cultures (MLC); absorbing lpr serum on protein G, adding antibody against transforming growth factor fl (TGF-fl) to cultures or dissociating immunoglobulin G (IgG) and TGF-fi before additions to cultures prevented suppression. Apparently autoantibody, similar to IgG produced by normal mice in response to immunization, carries TGF-fl which suppresses CTL responses in vivo and in vitro.
Ipr mice spontaneously develop autoimmunity which is characterized by progressively severe splenomegaly, lymphadenopathy, hypergammaglobulinemia, and immune deficiency, lpr mice carry a mutation of the FAS gene (1, 2) . How the absence of expression of the normal FAS gene product, which is involved in one pathway causing apoptosis, leads to autoimmunity is not understood; nevertheless, Ipr mice are considered a useful model for studying some aspects of autoimmunity, e.g., systemic SLE, that occur in humans (3) (4) (5) (6) (7) .
Normal mice immunized repeatedly with a single antigen develop high titers of specific antibody, and a small fraction of the specific IgG produced is associated with or carries TGF-fl which suppresses CD8 + CTL responses to unrelated antigens (8, 9) . We report here that IgG autoantibodies produced by lpr mice also have this property, and we suggest that such autoantibodies may play an important role in the pathogenesis of diseases caused by autoimmunity.
Materials and Methods
Mice, Sera, and Plasma. MRL/MpJ-Ipr (lpr) and MRL/MpJ-+ (+ +) (H2 t) females 5-6 wk old were purchased from The Jackson Laboratory (Bar Harbor, ME). BALB/c (H2 a) and C3H/HeN mammary tumor virus-negative (H2 k) females were purchased from the Frederick Cancer Research Production Facility (Frederick, MD). All mice were housed in the same barrier facility and fed sterile food and water. Most of the mice were small groups of three or four untreated, age-matched mice that became available to us at irregular intervals from another project. Anesthetized mice were exsanguinated by heart puncture. Sera were tested on the same day. Aliquots were diluted 1:10 in RPMI-1640 and concentrated into >100-kD fractions by filtration/centrifugation using Centricon microconcentrators (Amicon, Beverly, MA). The procedure reduced original volumes by 1.5-3-fold, and samples were stored at -80~ until used. The original volumes of fractionated sera were restored before dilution; dilutions of sera recorded are final concentrations in culture. Plasma was prepared from individual mice by diluting 50/A of fresh blood obtained from the orbital plexus in 950/zl complete medium; samples were centrifuged and the cell free supranatant was considered diluted 1:20. Sera were absorbed on protein G using HiTrapVMG (Pharmacia LKB Biotechnology, Uppsala, Sweden). Sera were diluted in a 0.1 M NaPO4 "binding buffer;" 1.0 ml aliquots was either untreated or added to columns (~2.0 min for additions and 10 min for absorption, the procedure repeated twice). Samples were diluted in complete media for testing in one-way MLC. Concentrations of IgG were determined in a modified ELISA assay using goat anti-routine IgG (H + L) conjugated to alkaline phosphatase (Calbiochem-Novabiochem Corp., La Jolla, CA).
Immunizations. Mice under light anesthesia were injected in each hind foot pad with 0.05/il of a suspension of either sheep erythrocytes (5%) or BALB/c spleen cells (2 x 108 cells/ml) suspended in RPMI-1640; injections were repeated every second day; mice were killed 4 and 6 d after the first injection for plaque forming cell (PFC) responses and 6 d after the first injection for CTL responses.
Cultures, Assays, and Reagents. Cell preparations, media, culture conditions, assays, and recording of data for CTL and PFC were the same as described in detail (8, 9) . For most experiments each one-way MLC contained 5 x 108 normal C3H spleen cells as responders and 5 x 10 s irradiated (2,000 rad) BALB/c spleen cells as stimulators in a final volume of 200 #1. In experiments comparing spleen cells from Ipr mice with spleen cells from control mice as responders in one-way MLC, cultures were set up in 24-(macrocultures) as well as in 96-well plates (microcultures). Cell number and volume were 10-fold higher in macrocultures. Monodonal murine antibody against murine TGF-/32, -~3 was lot B2332 from Genzyme Corp. (Cambridge, MA). 20/zl of antibody, 100 #g/ml, was added per culture of responder and stimulator cells 1 h before addition of murine serum to be tested. PFC/two lymph nodes from the two I U mice, and 13,000 and 14,000 PFC for lymph nodes from the two + + mice; all spleens contained 2,000-4,000 PFC. By 6 d 80-90% of PFC secreted IgG; responses for individual lpr mice were 9,000, 52,000, 54,000, and 109,000 PFC/two lymph nodes, and 65,000, 72,000, 126,000, and 152,000 PFC/two lymph nodes for + + mice. Responses in spleens were low but comparable for the two groups. Though not controlled within the experiment, the magnitude and variability of responses for both groups were comparable to responses we have observed in many experiments using C3H mice immunized in the same way.
Results

Young
In contrast to B cell responses, CTL responses stimulated by immunization with allogeneic spleen cells were approxi- 
Sera or Plasma from Ipr Mice Powerfully Suppresses CTL Responses in MLC.
In four consecutive experiments, pools of fresh sera were prepared from groups, three each, of agematched, untreated Iyr, + + mice and in two of the experiments pools from two C3H mice. Pools were tested on the same day in MLC. None of the pools from + + or C3H mice caused suppression at a dilution of 1:800; in contrast, all pools obtained from Ipr mice more than 6 wk old caused a greater than 4-10-fold suppression based on E/T ratios re-quired to cause comparable cytolysis of target cells (Table 1) . In a fifth experiment, fresh serum pooled from three 9-wkold Ipr mice also caused >10-fold suppression at a dilution of 1:800, whereas pooled sera from age-matched + + and C3H mice caused no suppression at this dilution (data not presented). Aliquots of these three pools were fractionated/concentrated and stored at -80~
The three pools were tested again 3 mo later; Ipr serum was again approximately 10 times more suppressive than the control sera whether estimated by comparing the E/T ratio required to cause equivalent cytolysis or estimated by comparing dilutions of serum causing equivalent suppression (Table 2) . These results using pooled sera were confirmed in a sixth experiment using fresh plasma from four Ipr and four + + 9-wk-old mice and assayed individually. The mean percent 5tCr-release for 12 control cultures with medium were 75, 54, and 26 at E/T ratios of 100:1, 25:1, and 6.2:1. All four plasma samples from lpr mice abolished CTL responses at dilutions of 1:600 and 1:1800. All four plasma samples from + + mice caused a less than twofold or no suppression at a dilution of 1:1800; at a dilution of 1:600, the lowest response at E/T ratios of 100:1, 25:1, and 6.2:1 was 32, 27, and 7% and the mean responses for the group were 50, 34, and 10% at these E/T ratios.
Suppression Caused by Ipr Serum Is Removed by Absorption on protein G or Is Prevented by Antibody to TGF-fl. Aliquots
of the same sera used in the experiment described in Table  2 (fractionated/concentrated, stored, and reconstituted) from 9-wk-old mice were either untreated or absorbed on protein G. The unbound and absorbed samples were then diluted in culture medium and added to MLC. Untreated Ipr serum caused >4-fold suppression at a dilution of 1:1200, data not shown, and >10-fold suppression at a dilution of 1:400. Absorption of Ipr serum on protein G greatly reduced suppression caused by serum diluted 1:400 (Fig. 2 A) . The control serum absorbed on protein G had no effect on CTL responses. Aliquots of the same sera from 9-wk-old mice were used in a separate experiment for testing the effect of anti-TGF-/~ antibody on suppression. In the experiment shown in Fig. Fig. 2 B) and did not affect responses to control serum. In other experiments, murine IgG2a of unknown specificity used at the same concentration as the anti-TGF-~ had no effect on CTL responses suppressed by immune sera. The results reported in Fig. 2 , A and B were confirmed using different pooled lpr and + + sera (data not shown).
B, lpr
Dissociation of lgG and 7-GF-fl Eliminates Suppression Caused by lpr Serum.
IgG from murine sera contains 1.0-10.0 ng Sera were pools from three Ipr, three + +, and two C3H mice; results are for >100-kD fractions reconstituted to equal the volume before fractionation. The numbers recorded are means _+ SD for 18 replicate cultures for medium and 3 replicate cultures for each serum dilution. latent TGF-/3/mg IgG; acidification of immune sera or purified IgG, pH 2.0, for 30 min, cleaved active TGF-/3 from the latent form carried by IgG (9). Acid-treated serum, though retaining full antibody activity and containing TGF-3 biologically active in a bioassay, no longer suppressed CTL responses in high dilution, presumably because IgG no longer focused through Fc receptors precise localization/activation of the latent TGF-3 carried by IgG (9) . Similarly acidification of lpr serum greatly reduced the capacity of lpr sera to suppress; for example in one experiment serum from lpr and + + mice were diluted 1:25 in normal saline; one aliquot was acidified to pH 2.0 with 1.2 N HC1 and neutralized with 0.72 N NaOH 30 min later; the same quantities of acid and base were added simultaneously to control aliquots at the beginning of the procedure. At the end of 30 min the samples were diluted in medium and added to MLC. The means for SlCr release of 20 control cultures with only medium or saline were 90, 82, and 49% at E/T ratios of 50:1, 12.5:1, and 3:1. Sera from + + mice, treated or untreated at a dilution of 1:400 had little or no effect on cultures. Sera from lpr mice treated simultaneously with acid and base abolished responses at a dilution of 1:400 (<10% SlCr release at all E/T ratios) and acidification for 30 min greatly reduced this suppression (70, 35, and 12% SlCr release at E/T ratios of 50:1, 12.5:1, and 3:1).
Discussion
Young (10, 11) which have specificities for epitopes on ribonucleoproteins, histones, and DNA (12) (13) (14) (15) ; the predominant isotype of these autoantibodies is IgG2a (16, 17) . 2-3-mo-old/pr mice have only slightly elevated serum IgG levels and probably do not have circulating antigenantibody complexes which appear later and cause complications such as nephritis in older ~r mice (6, 7) .
Collectively, the findings suggest that IgG autoantibodies, presumably of multiple specificities, and IgG antibodies produced in response to specific immunization are comparable for suppressing CTL responses, and in both cases suppression is mediated by TGF-/3 carried by IgG. Macrophages and functional Fc receptors are obligatory for IgG-TGF-B to cause suppression (9) . We have recently demonstrated that isolated single B cells secrete IgG-TGF-/~ with TGF-/$ in the latent form and that antigen-antibody complexes are not required and may interfere with suppression (our manuscript in preparation). Presumably IgG as a binding protein for the secretion of latent TGF-~ focuses through Fc receptors the local activation of TGF-~ by macrophages. CD8 + CTL are essential for effective host resistance to many, possibly all, viral infections (18) (19) (20) . We proposed that IgG-TGF-~ produced in response to a growing tumor or some viral infections might promote escape of tumor or viral variants that are observed to emerge during tumor growth or infection (8) . We now suggest that production of autoantibodies during the early stages of diseases such as SLE may suppress the capacity of the individual to respond effectively to first or new viral infections. For this reason viral infections which are relatively innocuous for normal individuals may complicate the pathogenesis of autoimmunity. It is also conceivable that TGF-/3 carried by IgG and focally activated where autoantibodies combine with autoantigens may stimulate connective tissue proliferation and scarring, characteristics of many autoimmune diseases.
We thank Dr. Daniel Magilavy, formerly of Department of Pediatrics, University of Chicago, for encouragement and the gift of most of the mice used in these experiments. This work was supported by grant R37 AI-10242 from the National Institutes of Health. Eric Becken, a fourth year student, St. Olaf College, Northfield, MN, was supported by a Howard Hughes Medical Institute Undergraduate Education grant to the University of Chicago.
